July 24, 2017
Otsuka Pharmaceutical Co., Ltd.
"Quick Navi-Flu2" Influenza Diagnostic Kit to Launch in Japan
- Otsuka's Quick Navi-Flu2, which launches on September 1, improves on current top-selling Quick Navi-Flu influenza diagnostic kit with a faster and clearer display of results
- Test results take five minutes. In over 90% of positive cases, results available within two minutes. Improved efficiency of influenza diagnosis can reduce the patient stay time in hospital
- Better visibility of improved latex particles allows healthcare practitioner to more clearly distinguish the results and provide appropriate treatment
Otsuka Pharmaceutical Co., Ltd. will commence sales to medical institutions in Japan from September 1, 2017, of the diagnostic test kit Quick Navi-Flu2, a new product in the Quick Navi Series of in vitro diagnostics. The kit improves on the best-selling Quick Navi-Flu diagnostic kit with a faster and clearer display of results. It facilitates more efficient diagnosis and improved influenza treatment.
Information in this news release was current as of the original release date.